VASGEN Ltd. logo

VASGEN Ltd.

Vasgen is a biotech company, developing targeted therapies for the treatment of cancer and ocular diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://vasgen.co.uk
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
The London Bioscience Innovation Centre2 Royal College Street, NW1 0NH
London
United Kingdom
Email
Contact Number
+44 207 691 2149

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/vasgen-limited” connections=”true” suffix=””]

Vasgens drug discovery platform AbIMP_ (Antibody Inhibitor of Metalloproteinases) are proto-type antibodies that display a high degree of selectivity for their ADAM targets and binds to an epitope comprising of key conserved and variable amino acids spanning the junction between the N-terminal and C-terminal sub-domains, proximal to the catalytic-cleft of the ADAM metalloproteinase domain.